Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease

European Heart Journal

Volumn 23, Issue 19, 2002, Pages 1509-1515

  Williams, Michael ^a,b   Stewart, Ralph ^a,b   McLelland, Marguerite ^a,b   Neal, Bruce ^a   Richards, Mark ^a,a   Simes, John ^a   Tonkin, Andrew ^a   Wilcken, David ^a   Murphy, Judy ^a   Cleverly, Yvonne ^a   Keech, Anthony ^a   Ohkubo, Takayoshi ^a   Bos, Kathy ^a   Bartram, Hazel ^a   Bennett, Derrick ^a   Broad, Joanna ^a   Douglas, Deanne ^a   Fisher, Sheila ^a   Gray, Barry ^a   Milne, Amanda ^a   McCulloch, Alan ^a   Ng, Colleen ^a   Pledger, Megan ^a   Pryor, Adrienne ^a   Santos, Aimee ^a   Slater, Alex ^a   Yiu, Karen ^a   Brnabic, Alan ^a   Woodward, Mark ^a   Burrell, Louise ^a   Brown, Louise ^a   Hamer, Angas ^a   Roberts, Louise ^a   Jeffery, Ian ^a   Taverner, Pearle ^a   Kam, Alice ^a   Aylward, Philip ^a   Wollaston, Fiona ^a   Whitehead, Anthony ^a   Lane, Geoffrey ^a   Tulloch, Gill ^a   Forrest, Nicole ^a   Garrett, Jan ^a   Aroney, Greg ^a   Hicks, Pam ^a   Silberberg, Jonathan ^a   Gordon, Anne ^a   Holliday, Julie ^a   Hicks, Liz ^a   Singh, Bhuwan ^a   Singh, Carol ^a   Wilken, Judi ^a   Jackson, Bruce ^a   Rudge, Gloria ^a   West, Malcolm ^a   Carle, Anne ^a   Marwick, Thomas ^a   Hall, Cindy ^a   Cross, David ^a   Craw, Daphne ^a   Hunt, David ^a,a   Sallaberger, Michelle ^a   Horowitz, John ^a   Worthley, Matthew ^a   Owen, Liz ^a   Owensby, Dwain ^a   McKenzie, Bill ^a   Kesby Smith, Julie ^a   MacKinley, Suzanne ^a   Sharpe, Norman ^a   Doughty, Robert ^a   Pomfret, Jenne ^a   Buttimore, Rona ^a   Skelton, Lorraine ^a   Luke, Richard ^a   Kenyon, Jane ^a   Mann, Stewart ^a   Cuthbert, Anne ^a   Reubin, Stuart ^a   Yorke, Pam ^a   Scott, Douglas ^a   Williams, Miles ^a   Coxon, Renee ^a   Fry, Darryl ^a   Clark, Malcolm ^a   Barclay, Pauline ^a   Hart, Hamish ^a   O'Toole, Carol ^a   Wright, Philippa ^a   Nairn, Leigh ^a   Bruning, Jeannie ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Coronary heart disease; Folic acid; Homocysteine; Randomized trial

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTEINE; FOLIC ACID; HOMOCYSTEINE; OMAPATRILAT; PLACEBO; THREONINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS; VITAMIN SUPPLEMENTATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRALIA; BIOLOGICAL MARKERS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HEMATINICS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PYRIDINES; THIAZEPINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036798802     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3161     Document Type: Article

References (16)

1. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
2. Perry IJ, Refsum H, Morriw RW et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
3. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
4. Boushey CJ, Beresford SAA, Omenn GS et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
5. Arnesen E, Refsum H, Bonaa K et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704-9.
6. Selhub J, Jacques PF, Wilson PW et al. Vitamin status and intake as primary determinants of homocysteinaemia in an elderly population. JAMA 1993; 270: 2693-8.
7. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. BMJ 1998; 316: 894-8.
8. Malinow M, Duell P, Hess D et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998; 338: 1009-15.
9. Brouwer I, Dusseldorp C, Thomas C et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomised trial. Am J Clin Nutr. 1999; 69: 99-104.
10. Appel L, Miller E, Jee S et al. Effect of dietary patterns on serum homocysteine: Results of a randomised, controlled feeding study. Circulation 2000; 22: 852-7.
11. MacMahon S. Blood pressure and the risk of cardiovascular disease. N Engl J Med 2000; 342: 50-2.
12. Wilcken D, Wang X, Adachi T et al. Relationship between homocysteine and superoxide dismutase in homocystinuria: Possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol 2000; 20: 1199-202.
13. Wilcken D, Wang X, Sim S et al. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C 677 T mutation. Arterioscler Thromb Vasc Biol. 1996; 16: 878-82.
14. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Goyette P, Summer J, Milos R et al. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195-200.
16. Brattstrom L, Wilcken D. Homocysteine and cardiovascular disease: Cause or effect? Am J Clin Nutr 2000; 72: 315-23.